QQQ   361.26 (+0.83%)
AAPL   173.75 (+1.48%)
MSFT   321.80 (+1.92%)
META   306.82 (+2.20%)
GOOGL   134.17 (+2.53%)
AMZN   129.46 (+1.84%)
TSLA   251.60 (+0.55%)
NVDA   447.82 (+2.95%)
NIO   8.79 (-2.77%)
BABA   86.53 (-0.24%)
AMD   103.27 (+0.44%)
T   14.67 (-2.33%)
F   12.31 (-0.97%)
MU   67.96 (-0.10%)
CGC   0.74 (-6.35%)
GE   108.79 (-1.59%)
DIS   81.67 (+0.76%)
AMC   8.16 (+2.00%)
PFE   33.94 (+2.32%)
PYPL   58.56 (+0.17%)
NFLX   380.33 (+0.72%)
QQQ   361.26 (+0.83%)
AAPL   173.75 (+1.48%)
MSFT   321.80 (+1.92%)
META   306.82 (+2.20%)
GOOGL   134.17 (+2.53%)
AMZN   129.46 (+1.84%)
TSLA   251.60 (+0.55%)
NVDA   447.82 (+2.95%)
NIO   8.79 (-2.77%)
BABA   86.53 (-0.24%)
AMD   103.27 (+0.44%)
T   14.67 (-2.33%)
F   12.31 (-0.97%)
MU   67.96 (-0.10%)
CGC   0.74 (-6.35%)
GE   108.79 (-1.59%)
DIS   81.67 (+0.76%)
AMC   8.16 (+2.00%)
PFE   33.94 (+2.32%)
PYPL   58.56 (+0.17%)
NFLX   380.33 (+0.72%)
QQQ   361.26 (+0.83%)
AAPL   173.75 (+1.48%)
MSFT   321.80 (+1.92%)
META   306.82 (+2.20%)
GOOGL   134.17 (+2.53%)
AMZN   129.46 (+1.84%)
TSLA   251.60 (+0.55%)
NVDA   447.82 (+2.95%)
NIO   8.79 (-2.77%)
BABA   86.53 (-0.24%)
AMD   103.27 (+0.44%)
T   14.67 (-2.33%)
F   12.31 (-0.97%)
MU   67.96 (-0.10%)
CGC   0.74 (-6.35%)
GE   108.79 (-1.59%)
DIS   81.67 (+0.76%)
AMC   8.16 (+2.00%)
PFE   33.94 (+2.32%)
PYPL   58.56 (+0.17%)
NFLX   380.33 (+0.72%)
QQQ   361.26 (+0.83%)
AAPL   173.75 (+1.48%)
MSFT   321.80 (+1.92%)
META   306.82 (+2.20%)
GOOGL   134.17 (+2.53%)
AMZN   129.46 (+1.84%)
TSLA   251.60 (+0.55%)
NVDA   447.82 (+2.95%)
NIO   8.79 (-2.77%)
BABA   86.53 (-0.24%)
AMD   103.27 (+0.44%)
T   14.67 (-2.33%)
F   12.31 (-0.97%)
MU   67.96 (-0.10%)
CGC   0.74 (-6.35%)
GE   108.79 (-1.59%)
DIS   81.67 (+0.76%)
AMC   8.16 (+2.00%)
PFE   33.94 (+2.32%)
PYPL   58.56 (+0.17%)
NFLX   380.33 (+0.72%)
NASDAQ:LBPH

Longboard Pharmaceuticals (LBPH) Institutional Ownership

$4.90
-0.66 (-11.87%)
(As of 10/2/2023 ET)
Compare
Today's Range
$4.75
▼
$5.87
50-Day Range
$4.90
▼
$7.49
52-Week Range
$2.70
▼
$10.29
Volume
58,337 shs
Average Volume
78,408 shs
Market Capitalization
$112.60 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$17.40
ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media

Institutional Ownership Changes (13F Filings) for Longboard Pharmaceuticals (NASDAQ:LBPH)

Current
Institutional Ownership
Percentage
63.28%
Number of
Institutional Buyers
(last 12 months)
26
Total
Institutional Inflows
(last 12 months)
$33.58 M
Number of
Institutional Sellers
(last 12 months)
6
Total
Institutional Outflows
(last 12 months)
$5.33 M
Get LBPH Insider Trade Alerts

Want to know when executives and insiders are buying or selling Longboard Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

LBPH Institutional Buying and Selling by Quarter


Longboard Pharmaceuticals Major Shareholders & Ownership History

Export to Excel
Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
8/21/2023California State Teachers Retirement System5,182$38K0.0%N/A0.023%
8/15/2023Wells Fargo & Company MN6,147$45K0.0%+6,439.4%0.027%
8/15/2023Goldman Sachs Group Inc.10,914$80K0.0%N/A0.047%
8/15/2023Point72 Asset Management L.P.825,000$6.06M0.0%-34.0%3.590%
8/15/2023Boothbay Fund Management LLC102,766$0.75M0.0%N/A0.447%
8/15/2023CIBC Asset Management Inc144,571$1.06M0.0%+157.6%0.629%
8/14/2023Schonfeld Strategic Advisors LLC87,000$0.64M0.0%N/A0.379%
8/14/2023State Street Corp294,485$2.16M0.0%N/A1.281%
8/14/2023Nuveen Asset Management LLC21,812$0.16M0.0%N/A0.095%
8/14/2023Prosight Management LP734,897$5.39M1.7%-18.4%3.198%
8/11/2023Renaissance Technologies LLC15,700$0.12M0.0%N/A0.068%
8/11/2023BlackRock Inc.740,603$5.44M0.0%+2,451.9%3.224%
8/11/2023The Manufacturers Life Insurance Company 38,803$0.29M0.0%+37.4%0.169%
8/11/2023Geode Capital Management LLC329,707$2.42M0.0%+302.5%1.435%
8/11/2023JPMorgan Chase & Co.567,305$4.16M0.0%N/A2.470%
8/11/2023Northern Trust Corp134,147$0.99M0.0%+654.1%0.584%
8/10/2023MetLife Investment Management LLC8,932$66K0.0%N/A0.039%
8/10/2023Charles Schwab Investment Management Inc.42,933$0.32M0.0%N/A0.187%
8/10/2023Citigroup Inc.4,638$34K0.0%+67.6%0.020%
8/9/2023TD Asset Management Inc48,611$0.36M0.0%+29.2%0.212%
8/4/2023American International Group Inc.7,498$55K0.0%N/A0.033%
8/3/2023Bank of New York Mellon Corp45,752$0.34M0.0%N/A0.199%
8/2/2023Bank of Montreal Can15,488$0.13M0.0%N/A0.067%
5/15/2023Price T Rowe Associates Inc. MD1,464,774$5.76M0.0%-3.1%6.378%
5/15/2023Farallon Capital Management LLC1,560,500$5.29M0.0%+92.5%6.795%
5/12/2023Prosight Management LP900,600$3.61M1.7%N/A3.922%
5/12/2023BlackRock Inc.29,022$0.12M0.0%+48.7%0.126%
5/12/2023CIBC Asset Management Inc56,125$0.23M0.0%N/A0.244%
5/11/2023FMR LLC2,900,392$11.40M0.0%+162.5%12.627%
5/9/2023Integral Health Asset Management LLC582,000$2.33M0.5%+139.5%2.534%
4/17/2023Bourgeon Capital Management LLC49,855$0.20M0.0%+1,324.4%0.217%
2/15/2023Millennium Management LLC987,712$3.12M0.0%-6.3%7.268%
11/15/2022BlackRock Inc.18,897$70K0.0%-13.0%0.139%
11/14/2022Cormorant Asset Management LP2,118,283$7.88M0.6%-6.8%15.592%
11/14/2022Integral Health Asset Management LLC110,000$0.41M0.1%+91.9%0.810%
8/15/2022Millennium Management LLC1,043,216$3.22M0.0%-0.3%7.679%
8/12/2022FMR LLC891,506$2.76M0.0%-15.0%6.560%
8/3/2022Integral Health Asset Management LLC57,335$0.18M0.0%+20.5%0.422%
5/12/2022Integral Health Asset Management LLC47,600$0.25M0.1%+58.7%0.350%
5/12/2022BlackRock Inc.30,669$0.16M0.0%+69.5%0.226%
5/12/2022Citigroup Inc.154,793$0.80M0.0%-22.6%1.139%
5/10/2022TD Asset Management Inc.37,624$0.20M0.0%-26.0%0.277%
4/25/2022Bailard Inc.21,200$0.11M0.0%N/A0.156%
2/10/2022Citigroup Inc.200,000$0.97M0.0%N/A1.472%
2/10/2022TD Asset Management Inc.50,850$0.25M0.0%-11.2%0.374%
11/15/2021Veritable L.P.20,534$0.18M0.0%N/A0.151%
11/9/2021TD Asset Management Inc.57,275$0.51M0.0%+237.1%0.421%
8/17/2021Price T Rowe Associates Inc. MD2,287,289$20.11M0.0%-0.7%16.836%
8/16/2021Alyeska Investment Group L.P.85,360$0.78M0.0%-31.7%0.628%
8/13/2021Renaissance Technologies LLC10,400$95K0.0%N/A0.077%
8/13/2021Laurion Capital Management LP20,918$0.19M0.0%-14.3%0.154%
8/13/2021Integral Health Asset Management LLC60,000$0.55M0.1%+100.0%0.442%
8/13/2021Vanguard Group Inc.165,545$1.51M0.0%+201.0%1.218%
8/13/2021FMR LLC2,037,831$18.59M0.0%+2.2%14.999%
5/27/2021Davidson Kempner Capital Management LP25,000$0.41M0.0%N/A0.184%
5/18/2021Millennium Management LLC190,349$3.11M0.0%N/A1.401%
5/18/2021Orbimed Advisors LLC300,000$4.91M0.0%N/A2.208%
5/18/2021Alyeska Investment Group L.P.125,000$2.05M0.0%N/A0.920%
5/18/2021Cormorant Asset Management LP2,356,000$37.19M0.8%N/A17.341%
5/18/2021Davidson Kempner Capital Management LP25,000$0.41M0.0%N/A0.184%
5/18/2021Citadel Advisors LLC181,473$2.96M0.0%N/A1.336%
5/18/2021Jane Street Group LLC10,606$0.17M0.0%N/A0.078%
5/17/2021Endurant Capital Management LP16,327$0.27M0.1%N/A0.120%
5/17/2021Price T Rowe Associates Inc. MD2,302,749$36.23M0.0%N/A16.949%
5/17/2021Goldman Sachs Group Inc.25,000$0.41M0.0%N/A0.184%
5/14/2021Laurion Capital Management LP24,400$0.40M0.0%N/A0.180%
5/14/2021TD Asset Management Inc.16,993$0.28M0.0%N/A0.100%
5/13/2021Citigroup Inc.405,645$6.62M0.0%N/A2.398%
(Data available from 1/1/2016 forward)













LBPH Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of LBPH shares?

During the previous two years, 33 institutional investors and hedge funds held shares of Longboard Pharmaceuticals. The most heavily invested institutionals were FMR LLC ($11.40M), Cormorant Asset Management LP ($7.88M), Point72 Asset Management L.P. ($6.06M), Price T Rowe Associates Inc. MD ($5.76M), BlackRock Inc. ($5.44M), Prosight Management LP ($5.39M), and Farallon Capital Management LLC ($5.29M).Learn more on LBPH's institutional investors.

What percentage of Longboard Pharmaceuticals stock is owned by institutional investors?

63.28% of Longboard Pharmaceuticals stock is owned by institutional investors. Learn more on LBPH's institutional investor holdings.

Which institutional investors have been buying Longboard Pharmaceuticals stock?

Of the 29 institutional investors that purchased Longboard Pharmaceuticals stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: FMR LLC ($1.80M), Prosight Management LP ($0.90M), Farallon Capital Management LLC ($0.75M), BlackRock Inc. ($0.73M), JPMorgan Chase & Co. ($0.57M), Integral Health Asset Management LLC ($0.42M), and State Street Corp ($0.29M).

How much institutional buying is happening at Longboard Pharmaceuticals?

Institutional investors have bought a total of 6,691,091 shares in the last 24 months. This purchase volume represents approximately $35.40M in transactions.

Which Longboard Pharmaceuticals major shareholders have been selling company stock?

Of the 9 institutional investors that sold Longboard Pharmaceuticals stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Point72 Asset Management L.P. ($0.43M), Prosight Management LP ($0.17M), FMR LLC ($0.16M), Cormorant Asset Management LP ($0.15M), Millennium Management LLC ($69.56K), Price T Rowe Associates Inc. MD ($46.19K), and Citigroup Inc. ($45.21K).

How much institutional selling is happening at Longboard Pharmaceuticals?

Institutional investors have sold a total of 1,086,536 shares in the last 24 months. This volume of shares sold represents approximately $6.16M in transactions.


Related Companies:
This page (NASDAQ:LBPH) was last updated on 10/2/2023 by MarketBeat.com Staff

My Account -